ID   DUS18_HUMAN             Reviewed;         188 AA.
AC   Q8NEJ0; B3KPA4;
DT   28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   07-APR-2021, entry version 148.
DE   RecName: Full=Dual specificity protein phosphatase 18;
DE            EC=3.1.3.16 {ECO:0000269|PubMed:12408986, ECO:0000269|PubMed:12591617};
DE            EC=3.1.3.48 {ECO:0000269|PubMed:12408986, ECO:0000269|PubMed:12591617};
DE   AltName: Full=Low molecular weight dual specificity phosphatase 20 {ECO:0000303|PubMed:12408986};
DE            Short=LMW-DSP20;
GN   Name=DUSP18; Synonyms=LMWDSP20;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], CHARACTERIZATION, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, CATALYTIC ACTIVITY, AND FUNCTION.
RC   TISSUE=Colon tumor;
RX   PubMed=12408986; DOI=10.1016/s0006-291x(02)02488-9;
RA   Hood K.L., Tobin J.F., Yoon C.;
RT   "Identification and characterization of two novel low-molecular-weight dual
RT   specificity phosphatases.";
RL   Biochem. Biophys. Res. Commun. 298:545-551(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL
RP   PROPERTIES, FUNCTION, ACTIVITY REGULATION, TISSUE SPECIFICITY, AND
RP   MUTAGENESIS OF ASP-73; LEU-102; CYS-104; ARG-110 AND SER-111.
RC   TISSUE=Fetal brain;
RX   PubMed=12591617; DOI=10.1016/s0167-4781(02)00629-2;
RA   Wu Q., Gu S., Dai J., Dai J., Wang L., Li Y., Zeng L., Xu J., Ye X.,
RA   Zhao W., Ji C., Xie Y., Mao Y.;
RT   "Molecular cloning and characterization of a novel dual-specificity
RT   phosphatase18 gene from human fetal brain.";
RL   Biochim. Biophys. Acta 1625:296-304(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS).
RX   PubMed=16699184; DOI=10.1107/s0907444906010109;
RA   Jeong D.G., Cho Y.H., Yoon T.S., Kim J.H., Son J.H., Ryu S.E., Kim S.J.;
RT   "Structure of human DSP18, a member of the dual-specificity protein
RT   tyrosine phosphatase family.";
RL   Acta Crystallogr. D 62:582-588(2006).
CC   -!- FUNCTION: Can dephosphorylate single and diphosphorylated synthetic
CC       MAPK peptides, with preference for the phosphotyrosine and
CC       diphosphorylated forms over phosphothreonine. In vitro,
CC       dephosphorylates p-nitrophenyl phosphate (pNPP).
CC       {ECO:0000269|PubMed:12408986, ECO:0000269|PubMed:12591617}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O-phospho-L-tyrosyl-[protein] = L-tyrosyl-[protein] +
CC         phosphate; Xref=Rhea:RHEA:10684, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620; EC=3.1.3.48; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU10044, ECO:0000269|PubMed:12408986,
CC         ECO:0000269|PubMed:12591617};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O-phospho-L-seryl-[protein] = L-seryl-[protein] +
CC         phosphate; Xref=Rhea:RHEA:20629, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15377, ChEBI:CHEBI:29999, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:83421; EC=3.1.3.16;
CC         Evidence={ECO:0000269|PubMed:12408986, ECO:0000269|PubMed:12591617};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O-phospho-L-threonyl-[protein] = L-threonyl-[protein] +
CC         phosphate; Xref=Rhea:RHEA:47004, Rhea:RHEA-COMP:11060, Rhea:RHEA-
CC         COMP:11605, ChEBI:CHEBI:15377, ChEBI:CHEBI:30013, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:61977; EC=3.1.3.16;
CC         Evidence={ECO:0000269|PubMed:12408986, ECO:0000269|PubMed:12591617};
CC   -!- ACTIVITY REGULATION: Activated by manganese ions, inhibited by
CC       iodoaretic acid. {ECO:0000269|PubMed:12591617}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Optimum pH is 6.0. {ECO:0000269|PubMed:12591617};
CC       Temperature dependence:
CC         Optimum temperature is 55 degrees Celsius.
CC         {ECO:0000269|PubMed:12591617};
CC   -!- INTERACTION:
CC       Q8NEJ0; P06213: INSR; NbExp=2; IntAct=EBI-10698945, EBI-475899;
CC       Q8NEJ0; Q8WXH2: JPH3; NbExp=3; IntAct=EBI-10698945, EBI-1055254;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12408986}. Nucleus
CC       {ECO:0000269|PubMed:12408986}. Mitochondrion inner membrane
CC       {ECO:0000250|UniProtKB:Q8VE01}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:Q8VE01}; Intermembrane side
CC       {ECO:0000250|UniProtKB:Q8VE01}. Note=Translocates to cytoplasm in
CC       response to apoptotic stimuli such as staurosporine treatment.
CC       {ECO:0000250|UniProtKB:Q8VE01}.
CC   -!- TISSUE SPECIFICITY: Widely expressed with highest levels in liver,
CC       brain, ovary and testis. {ECO:0000269|PubMed:12408986,
CC       ECO:0000269|PubMed:12591617}.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family. Non-
CC       receptor class dual specificity subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF533017; AAN59787.1; -; mRNA.
DR   EMBL; AF461689; AAN77931.1; -; mRNA.
DR   EMBL; CR456406; CAG30292.1; -; mRNA.
DR   EMBL; AK056074; BAG51616.1; -; mRNA.
DR   EMBL; CH471095; EAW59913.1; -; Genomic_DNA.
DR   EMBL; BC030987; AAH30987.1; -; mRNA.
DR   CCDS; CCDS13883.1; -.
DR   RefSeq; NP_001291723.1; NM_001304794.1.
DR   RefSeq; NP_001291724.1; NM_001304795.1.
DR   RefSeq; NP_689724.3; NM_152511.4.
DR   RefSeq; XP_005261425.1; XM_005261368.4.
DR   RefSeq; XP_006724211.1; XM_006724148.3.
DR   RefSeq; XP_011528222.1; XM_011529920.2.
DR   RefSeq; XP_011528223.1; XM_011529921.2.
DR   RefSeq; XP_016884116.1; XM_017028627.1.
DR   RefSeq; XP_016884117.1; XM_017028628.1.
DR   PDB; 2ESB; X-ray; 2.00 A; A=1-188.
DR   PDBsum; 2ESB; -.
DR   SMR; Q8NEJ0; -.
DR   BioGRID; 127280; 21.
DR   IntAct; Q8NEJ0; 15.
DR   MINT; Q8NEJ0; -.
DR   STRING; 9606.ENSP00000333917; -.
DR   DEPOD; DUSP18; -.
DR   PhosphoSitePlus; Q8NEJ0; -.
DR   BioMuta; DUSP18; -.
DR   DMDM; 29840768; -.
DR   MassIVE; Q8NEJ0; -.
DR   MaxQB; Q8NEJ0; -.
DR   PaxDb; Q8NEJ0; -.
DR   PeptideAtlas; Q8NEJ0; -.
DR   PRIDE; Q8NEJ0; -.
DR   ProteomicsDB; 73168; -.
DR   Antibodypedia; 24819; 40 antibodies.
DR   DNASU; 150290; -.
DR   Ensembl; ENST00000334679; ENSP00000333917; ENSG00000167065.
DR   Ensembl; ENST00000377087; ENSP00000366291; ENSG00000167065.
DR   Ensembl; ENST00000404885; ENSP00000385463; ENSG00000167065.
DR   Ensembl; ENST00000407308; ENSP00000386063; ENSG00000167065.
DR   GeneID; 150290; -.
DR   KEGG; hsa:150290; -.
DR   UCSC; uc003aiu.4; human.
DR   CTD; 150290; -.
DR   GeneCards; DUSP18; -.
DR   HGNC; HGNC:18484; DUSP18.
DR   HPA; ENSG00000167065; Low tissue specificity.
DR   MIM; 611446; gene.
DR   neXtProt; NX_Q8NEJ0; -.
DR   OpenTargets; ENSG00000167065; -.
DR   PharmGKB; PA134928498; -.
DR   VEuPathDB; HostDB:ENSG00000167065.13; -.
DR   eggNOG; KOG1718; Eukaryota.
DR   GeneTree; ENSGT00940000161186; -.
DR   InParanoid; Q8NEJ0; -.
DR   OMA; HVQAIRP; -.
DR   OrthoDB; 1576308at2759; -.
DR   PhylomeDB; Q8NEJ0; -.
DR   TreeFam; TF316009; -.
DR   PathwayCommons; Q8NEJ0; -.
DR   BioGRID-ORCS; 150290; 3 hits in 988 CRISPR screens.
DR   ChiTaRS; DUSP18; human.
DR   EvolutionaryTrace; Q8NEJ0; -.
DR   GeneWiki; DUSP18; -.
DR   GenomeRNAi; 150290; -.
DR   Pharos; Q8NEJ0; Tbio.
DR   PRO; PR:Q8NEJ0; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   RNAct; Q8NEJ0; protein.
DR   Bgee; ENSG00000167065; Expressed in secondary oocyte and 181 other tissues.
DR   ExpressionAtlas; Q8NEJ0; baseline and differential.
DR   Genevisible; Q8NEJ0; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0017017; F:MAP kinase tyrosine/serine/threonine phosphatase activity; IEA:InterPro.
DR   GO; GO:0016791; F:phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0106306; F:protein serine phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0106307; F:protein threonine phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0016311; P:dephosphorylation; IDA:UniProtKB.
DR   GO; GO:0035970; P:peptidyl-threonine dephosphorylation; IDA:UniProtKB.
DR   GO; GO:0035335; P:peptidyl-tyrosine dephosphorylation; IDA:UniProtKB.
DR   Gene3D; 3.90.190.10; -; 1.
DR   InterPro; IPR020420; Atypical_DUSP_subfamB.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   InterPro; IPR020422; TYR_PHOSPHATASE_DUAL_dom.
DR   PRINTS; PR01910; ADSPHPHTASEB.
DR   SMART; SM00195; DSPc; 1.
DR   SUPFAM; SSF52799; SSF52799; 1.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
DR   PROSITE; PS50054; TYR_PHOSPHATASE_DUAL; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; Hydrolase; Membrane; Mitochondrion;
KW   Mitochondrion inner membrane; Nucleus; Protein phosphatase;
KW   Reference proteome.
FT   CHAIN           1..188
FT                   /note="Dual specificity protein phosphatase 18"
FT                   /id="PRO_0000094828"
FT   DOMAIN          19..160
FT                   /note="Tyrosine-protein phosphatase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00160"
FT   ACT_SITE        104
FT                   /note="Phosphocysteine intermediate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00160"
FT   MUTAGEN         73
FT                   /note="D->A: Abolishes most of in vitro phosphatase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:12591617"
FT   MUTAGEN         102
FT                   /note="L->V: No effect on in vitro phosphatase activity."
FT                   /evidence="ECO:0000269|PubMed:12591617"
FT   MUTAGEN         104
FT                   /note="C->S: Abolishes most of in vitro phosphatase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:12591617"
FT   MUTAGEN         110
FT                   /note="R->K: Abolishes most of in vitro phosphatase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:12591617"
FT   MUTAGEN         111
FT                   /note="S->A: Abolishes most of in vitro phosphatase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:12591617"
FT   CONFLICT        2
FT                   /note="T -> A (in Ref. 2; AAN77931)"
FT                   /evidence="ECO:0000305"
FT   STRAND          21..24
FT                   /evidence="ECO:0007744|PDB:2ESB"
FT   STRAND          27..30
FT                   /evidence="ECO:0007744|PDB:2ESB"
FT   HELIX           34..36
FT                   /evidence="ECO:0007744|PDB:2ESB"
FT   HELIX           38..43
FT                   /evidence="ECO:0007744|PDB:2ESB"
FT   STRAND          48..51
FT                   /evidence="ECO:0007744|PDB:2ESB"
FT   STRAND          65..68
FT                   /evidence="ECO:0007744|PDB:2ESB"
FT   HELIX           79..82
FT                   /evidence="ECO:0007744|PDB:2ESB"
FT   HELIX           83..95
FT                   /evidence="ECO:0007744|PDB:2ESB"
FT   STRAND          100..103
FT                   /evidence="ECO:0007744|PDB:2ESB"
FT   STRAND          105..109
FT                   /evidence="ECO:0007744|PDB:2ESB"
FT   HELIX           110..122
FT                   /evidence="ECO:0007744|PDB:2ESB"
FT   HELIX           127..137
FT                   /evidence="ECO:0007744|PDB:2ESB"
FT   HELIX           145..159
FT                   /evidence="ECO:0007744|PDB:2ESB"
FT   HELIX           176..178
FT                   /evidence="ECO:0007744|PDB:2ESB"
SQ   SEQUENCE   188 AA;  21066 MW;  A6EDECC3624F570F CRC64;
     MTAPSCAFPV QFRQPSVSGL SQITKSLYIS NGVAANNKLM LSSNQITMVI NVSVEVVNTL
     YEDIQYMQVP VADSPNSRLC DFFDPIADHI HSVEMKQGRT LLHCAAGVSR SAALCLAYLM
     KYHAMSLLDA HTWTKSCRPI IRPNSGFWEQ LIHYEFQLFG KNTVHMVSSP VGMIPDIYEK
     EVRLMIPL
//
